2196 fundamentals
An in-depth look to SHANGHAI FOSUN PHARMACEUTICAL GROUP operating, investing, and financing activities
2196 free cash flow for H2 23 is -503.53 M HKD. For 2023, 2196 free cash flow was -2.45 B HKD and operating cash flow was 3.44 B HKD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
TTM